Amyloid-β and Hyperphosphorylated tau Synergy Drives Clinical Progression in Individuals with Mild Cognitive Impairment

被引：0
|
作者：
Pascoal, Tharick [2 ]
Benedet, Andrea [2 ]
Mathotaarachchi, Sulantha [2 ]
Soucy, Jean-Paul
Beaudry, Tom [2 ]
Gauthier, Serge [1 ]
Neto, Pedro Rosa [2 ]
机构：
[1] Douglas Hosp, Verdun, PQ, Canada
[2] McGill Univ, Montreal, PQ, Canada
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P2.228
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Amyloid-β and Hyperphosphorylated tau Synergy Drives Metabolic Decline in Preclinical Alzheimer's Disease
    Pascoal, Tharick
    Mathotaarachchi, Sulantha
    Benedet, Andrea
    Beaudry, Tom
    Gauther, Serge
    Neto, Pedro Rosa
    [J]. NEUROLOGY, 2016, 86
  • [2] Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease
    T A Pascoal
    S Mathotaarachchi
    S Mohades
    A L Benedet
    C-O Chung
    M Shin
    S Wang
    T Beaudry
    M S Kang
    J-P Soucy
    A Labbe
    S Gauthier
    P Rosa-Neto
    [J]. Molecular Psychiatry, 2017, 22 : 306 - 311
  • [3] Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
    Pascoal, T. A.
    Mathotaarachchi, S.
    Mohades, S.
    Benedet, A. L.
    Chung, C-O
    Shin, M.
    Wang, S.
    Beaudry, T.
    Kang, M. S.
    Soucy, J-P
    Labbe, A.
    Gauthier, S.
    Rosa-Neto, P.
    [J]. MOLECULAR PSYCHIATRY, 2017, 22 (02) : 306 - 311
  • [4] Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
    Wei Hong-Chun
    Li Bing
    Ng Kok Pin
    Fu Qing-Xi
    Dong Sheng-Jie
    Ba Mao-Wen
    Kong Min
    [J]. 中华医学杂志(英文版), 2021, 134 (14) : 1709 - 1719
  • [5] Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
    Wei, Hong-Chun
    Li, Bing
    Ng, Kok Pin
    Fu, Qing-Xi
    Dong, Sheng-Jie
    Ba, Mao-Wen
    Kong, Min
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (14) : 1709 - 1719
  • [6] Corrigendum: Amyloid and tau positive mild cognitive impairment: clinical and biomarker characteristics of dementia progression
    [J]. 中华医学杂志(英文版), 2021, (17) : 2139 - 2139
  • [7] Comparable brain levels of amyloid-β and tau in asymptomatic AD and mild cognitive impairment
    [J]. Nature Reviews Neurology, 2014, 10 (4) : 181 - 181
  • [8] Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
    Huijbers, Willem
    Mormino, Elizabeth C.
    Schultz, Aaron P.
    Wigman, Sarah
    Ward, Andrew M.
    Larvie, Mykol
    Amariglio, Rebecca E.
    Marshall, Gad A.
    Rentz, Dorene M.
    Johnson, Keith A.
    Sperling, Reisa A.
    [J]. BRAIN, 2015, 138 : 1023 - 1035
  • [9] The spatial distribution of coupling between tau and neurodegeneration in amyloid-β positive mild cognitive impairment
    Robinson, Belfin
    Bhamidi, Shankar
    Dayan, Eran
    [J]. NEUROBIOLOGY OF AGING, 2024, 136 : 70 - 77
  • [10] Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment
    Malpas, Charles B.
    Saling, Michael M.
    Velakoulis, Dennis
    Desmond, Patricia
    O'Brien, Terence J.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (04) : 965 - 975
12345